137 related articles for article (PubMed ID: 9829279)
1. Dystrophinopathy in a boy with Chediak-Higashi syndrome.
von Moers A; van Landeghem FK; Cohn RD; Baumgarten E; Bürger J; Stoltenburg-Didinger G
Neuromuscul Disord; 1998 Oct; 8(7):489-94. PubMed ID: 9829279
[TBL] [Abstract][Full Text] [Related]
2. A novel frameshift mutation of Chediak-Higashi syndrome and treatment in the accelerated phase.
Wu XL; Zhao XQ; Zhang BX; Xuan F; Guo HM; Ma FT
Braz J Med Biol Res; 2017 Mar; 50(4):e5727. PubMed ID: 28355352
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the Chediak-Higashi syndrome gene (CHS1) indicate requirement for the complete 3801 amino acid CHS protein.
Karim MA; Nagle DL; Kandil HH; Bürger J; Moore KJ; Spritz RA
Hum Mol Genet; 1997 Jul; 6(7):1087-9. PubMed ID: 9215679
[TBL] [Abstract][Full Text] [Related]
4. Chédiak-Higashi syndrome with novel gene mutation.
Helmi MM; Saleh M; Yacop B; ElSawy D
BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28183707
[TBL] [Abstract][Full Text] [Related]
5. Chediak-Higashi syndrome presenting in accelerated phase: A case report and literature review.
Maaloul I; Talmoudi J; Chabchoub I; Ayadi L; Kamoun TH; Boudawara T; Kallel CH; Hachicha M
Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):71-5. PubMed ID: 26254864
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcomes of chédiak-Higashi syndrome: a nationwide survey of Japan.
Nagai K; Ochi F; Terui K; Maeda M; Ohga S; Kanegane H; Kitoh T; Kogawa K; Suzuki N; Ohta S; Ishida Y; Okamura T; Wakiguchi H; Yasukawa M; Ishii E
Pediatr Blood Cancer; 2013 Oct; 60(10):1582-6. PubMed ID: 23804531
[TBL] [Abstract][Full Text] [Related]
7. A clinical report of Chediak-Higashi syndrome in infancy with a novel genotype from the Indian subcontinent.
Singh A; Bryan MM; Roney JC; Cullinane AR; Gahl WA; Khurana N; Kapoor S
Int J Dermatol; 2016 Mar; 55(3):317-21. PubMed ID: 26499269
[TBL] [Abstract][Full Text] [Related]
8. A novel single point mutation of the LYST gene in two siblings with different phenotypic features of Chediak Higashi syndrome.
Kaya Z; Ehl S; Albayrak M; Maul-Pavicic A; Schwarz K; Kocak U; Ergun MA; Gursel T
Pediatr Blood Cancer; 2011 Jul; 56(7):1136-9. PubMed ID: 21488161
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of clinical characteristics and genetic mutation in a pedigree affected with Chediak-Higashi syndrome].
Zhao J; Wang Z; Zhang L; Sun H; Yang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Apr; 35(2):188-192. PubMed ID: 29652989
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin.
Matsumura K; Tomé FM; Ionasescu V; Ervasti JM; Anderson RD; Romero NB; Simon D; Récan D; Kaplan JC; Fardeau M
J Clin Invest; 1993 Aug; 92(2):866-71. PubMed ID: 8349821
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
Mizuno Y; Nonaka I; Hirai S; Ozawa E
J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
[TBL] [Abstract][Full Text] [Related]
12. Protein truncation test of LYST reveals heterogenous mutations in patients with Chediak-Higashi syndrome.
Certain S; Barrat F; Pastural E; Le Deist F; Goyo-Rivas J; Jabado N; Benkerrou M; Seger R; Vilmer E; Beullier G; Schwarz K; Fischer A; de Saint Basile G
Blood; 2000 Feb; 95(3):979-83. PubMed ID: 10648412
[TBL] [Abstract][Full Text] [Related]
13. Chediak-Higashi syndrome presenting in accelerated phase.
Imran T; Zafar L; Rehan M; Nasir A; Tariq PA; Batool I
J Coll Physicians Surg Pak; 2012 Aug; 22(8):539-41. PubMed ID: 22868026
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Partial Uniparental Disomy Unmasks a Novel Recessive Mutation in the
Boluda-Navarro M; Ibáñez M; Liquori A; Franco-Jarava C; Martínez-Gallo M; Rodríguez-Vega H; Teresa J; Carreras C; Such E; Zúñiga Á; Colobran R; Cervera JV
Front Immunol; 2021; 12():625591. PubMed ID: 33868243
[TBL] [Abstract][Full Text] [Related]
15. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
Arahata K; Beggs AH; Honda H; Ito S; Ishiura S; Tsukahara T; Ishiguro T; Eguchi C; Orimo S; Arikawa E
J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
[TBL] [Abstract][Full Text] [Related]
16. A Japanese family with two types of muscular dystrophy: DNA analysis and the dystrophin test.
Matsumura K; Toda T; Hasegawa T; Kamei M; Imoto N; Shimizu T
J Child Neurol; 1991 Jul; 6(3):251-6. PubMed ID: 1875028
[TBL] [Abstract][Full Text] [Related]
17. Dystrophin negative skeletal and myocardial muscle cells in a carrier of Duchenne's muscular dystrophy.
Watanabe K; Izumi T; Natsui M; Matsubara N; Miyakita Y; Koyama S; Inomata T; Suzuki M; Shibata A
Eur Heart J; 1993 Jul; 14(7):989-92. PubMed ID: 8375425
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis and clinical aspects of four patients with Chédiak-Higashi syndrome (CHS).
Scherber E; Beutel K; Ganschow R; Schulz A; Janka G; Stadt Uz
Clin Genet; 2009 Oct; 76(4):409-12. PubMed ID: 19650863
[No Abstract] [Full Text] [Related]
19. Inflammatory demyelinating neuropathy heralding accelerated chediak-higashi syndrome.
Faber IV; Prota JRM; Martinez ARM; Nucci A; Lopes-Cendes I; Júnior MCF
Muscle Nerve; 2017 May; 55(5):756-760. PubMed ID: 27669550
[TBL] [Abstract][Full Text] [Related]
20. Dystrophin or a "related protein" in Duchenne muscular dystrophy?
Nicholson LV; Johnson MA; Davison K; O'Donnell E; Falkous G; Barron M; Harris JB
Acta Neurol Scand; 1992 Jul; 86(1):8-14. PubMed ID: 1519480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
